A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
Matthew D. J. Dicks(University of Oxford), Matthew G. Cottingham(University of Oxford), Alexandra J. Spencer(University of Oxford), Sarah C. Gilbert(Nuffield Orthopaedic Centre), Nick J. Edwards(University of Oxford), Adrian V. S. Hill(Jenner Institute), Göran Wadell(Umeå University), Kalifa Bojang(MRC Unit the Gambia)
Cited by 398
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
|Cell|2021|1.2k
Antibody evasion by the P.1 strain of SARS-CoV-2
|Cell|2021|661